about
Identification of C-terminal Hsp70-interacting protein as a mediator of tumour necrosis factor action in osteoblast differentiation by targeting osterix for degradationBone formation rather than inflammation reflects ankylosing spondylitis activity on PET-CT: a pilot studyHigh bone turnover assessed by 18F-fluoride PET/CT in the spine and sacroiliac joints of patients with ankylosing spondylitis: comparison with inflammatory lesions detected by whole body MRI.Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitorsThe balance of tissue repair and remodeling in chronic arthritis.Is psoriatic arthritis a result of abnormalities in acquired or innate immunity?Baseline increased 18F-fluoride uptake lesions at vertebral corners on positron emission tomography predict new syndesmophyte development in ankylosing spondylitis: a 2-year longitudinal study.Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis.The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis.IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells.Disease-modifying effect of etanercept versus sulphasalazine on spinal mobility in patients with ankylosing spondylitis.Serum leptin levels are associated with the presence of syndesmophytes in male patients with ankylosing spondylitis.
P2860
Q35995064-3929BE05-F21E-447C-84E1-1D66CFE73C45Q36245785-991D5929-D9F4-4C87-957B-B9EB9F3882FFQ36320058-7556208B-585E-4D01-9451-BBC1939E980CQ36907665-53938B2D-579D-4221-A32C-86CFCD335828Q37947117-E629220A-5854-4B10-BA51-D60928B1EE1DQ38004958-2ACC8464-93EB-49B1-A903-3139E3A6B780Q38762450-A6F9BE2C-F5DC-4030-B93E-6CCF82779410Q38925780-F6444D89-5B78-47FF-9729-5F063FFB3BD4Q42597088-83D495F6-8AB8-4ADD-969E-0433CBB1EDA0Q44934503-8B276F48-3EFE-4CE7-8ED0-1257F24F19C8Q46043893-C8ACF3BC-3F7E-43DE-A3DF-9B0EE9D55770Q46050990-78BE40E6-195B-429E-97BE-F2D02BA7EAEDQ53374383-5E1CD9A1-14AE-41CB-B2B5-F6BF71BEAB26
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Disease modification in ankylosing spondylitis.
@en
Disease modification in ankylosing spondylitis.
@nl
type
label
Disease modification in ankylosing spondylitis.
@en
Disease modification in ankylosing spondylitis.
@nl
prefLabel
Disease modification in ankylosing spondylitis.
@en
Disease modification in ankylosing spondylitis.
@nl
P2860
P356
P1476
Disease modification in ankylosing spondylitis.
@en
P2093
Walter P Maksymowych
P2860
P2888
P356
10.1038/NRRHEUM.2009.258
P407
P577
2010-02-01T00:00:00Z